大型医疗系统中皮肤科医生检测皮肤癌的成本估算
该回顾性观察研究分析了2011-2015年间20270例接受全身皮肤检查的患者,共行9956次活检,检出2763例皮肤癌(含155例黑色素瘤)。检出1例皮肤癌需筛查12.2人,检出1例黑色素瘤需筛查215人;每检出1例黑色素瘤的估计成本为32594美元。黑色素瘤检测在≥50岁或有个人黑色素瘤史的患者中效率最高。
要点
- 全身皮肤检查检出1例皮肤癌需筛查12.2人,检出1例黑色素瘤需筛查215人。
- 每检出1例黑色素瘤的估计成本为32594美元(95%CI 27326-37475)。
- 年龄和个人黑色素瘤史是筛查效率的显著影响因素,51岁为风险转折点。
核心结论
- 通过全身皮肤检查检出黑色素瘤在≥50岁或有个人黑色素瘤史的患者中效率最高。
- 研究结果有助于对皮肤科医生黑色素瘤筛查的成本效果进行建模。
研究设计与样本
- 回顾性观察研究,纳入2011-2015年间在大型皮肤科诊所接受全身皮肤检查的20270例患者,共33647次就诊。
主要发现
- 共进行9956次病灶活检,检出2763例皮肤癌,包括155例黑色素瘤。
- 检出1例皮肤癌的需筛查人数(NNS)为12.2(95%CI 11.7-12.6),检出1例黑色素瘤的NNS为215(95%CI 185-252)。
- 检出1例皮肤癌的需活检人数(NNB)为3.0(95%CI 2.9-3.1),检出1例黑色素瘤的NNB为27.8(95%CI 23.3-33.3)。
- 在多变量模型中,年龄和个人黑色素瘤史是NNS的显著影响因素,年龄在51岁时从保护因素转为风险因素。
- 每检出1例黑色素瘤的估计成本为32594美元(95%CI 27326-37475)。
关键数值与推荐
- 检出1例皮肤癌的NNS为12.2(95%CI 11.7-12.6),检出1例黑色素瘤的NNS为215(95%CI 185-252)。
- 检出1例皮肤癌的NNB为3.0(95%CI 2.9-3.1),检出1例黑色素瘤的NNB为27.8(95%CI 23.3-33.3)。
- 每检出1例黑色素瘤的估计成本为32594美元(95%CI 27326-37475)。
临床怎么用
- 对于≥50岁或有个人黑色素瘤史的患者,全身皮肤检查检出黑色素瘤的效率更高。
- 可利用NNS、NNB和每例黑色素瘤检出成本数据评估筛查方案的成本效果。
局限性
- 数据来自单一医疗系统,且基于医生编码。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on the cost and efficiency of skin cancer detection through total body skin examination are scarce. OBJECTIVE: To determine the number needed to screen (NNS) and biopsy (NNB) and cost per skin cancer diagnosed in a large dermatology practice in patients undergoing total body skin examination. METHODS: This is a retrospective observational study. RESULTS: During 2011-2015, a total of 20,270 patients underwent 33,647 visits for total body skin examination; 9956 lesion biopsies were performed yielding 2763 skin cancers, including 155 melanomas. The NNS to detect 1 skin cancer was 12.2 (95% confidence interval [CI] 11.7-12.6) and 1 melanoma was 215 (95% CI 185-252). The NNB to detect 1 skin cancer was 3.0 (95% CI 2.9-3.1) and 1 melanoma was 27.8 (95% CI 23.3-33.3). In a multivariable model for NNS, age and personal history of melanoma were significant factors. Age switched from a protective factor to a risk factor at 51 years of age. The estimated cost per melanoma detected was $32,594 (95% CI $27,326-$37,475). LIMITATIONS: Data are from a single health care system and based on physician coding. CONCLUSION: Melanoma detection through total body skin examination is most efficient in patients ≥50 years of age and those with a personal history of melanoma. Our findings will be helpful in modeling the cost effectiveness of melanoma screening by dermatologists.
引用
- Matsumoto M, Secrest A, Anderson A, et al. Estimating the cost of skin cancer detection by dermatology providers in a large health care system. J Am Acad Dermatol. 2017. PMID: 29180093. doi:10.1016/j.jaad.2017.11.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。